Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C23H17NO6 and a molecular weight of approximately 403.39 g/mol[3][5][9]. It is known by the code names WH6 and PD004171 and has been referenced in drug research databases as an experimental agent[10]. The structure features a phthalimide (isoindole dione) core substituted with a naphthalene-containing side chain. There is no evidence that it has reached clinical development or approval for any therapeutic indication. Its mechanism of action and biological targets are not described in public sources; it appears to be primarily used as a chemical probe or experimental tool compound in research settings[10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid.